Michael Bogwitz

ORCID: 0000-0002-3293-9157
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Genomics and Rare Diseases
  • Cancer Genomics and Diagnostics
  • Insect Resistance and Genetics
  • Counseling Practices and Supervision
  • Genetic factors in colorectal cancer
  • Cardiomyopathy and Myosin Studies
  • Cancer Risks and Factors
  • Vascular Anomalies and Treatments
  • Neurobiology and Insect Physiology Research
  • Ethics in Clinical Research
  • Genomic variations and chromosomal abnormalities
  • Cardiac electrophysiology and arrhythmias
  • CRISPR and Genetic Engineering
  • Tracheal and airway disorders
  • Renal and related cancers
  • DNA Repair Mechanisms
  • Chromosomal and Genetic Variations
  • Invertebrate Immune Response Mechanisms
  • Genetic Associations and Epidemiology
  • Epigenetics and DNA Methylation
  • Family Support in Illness
  • Biomedical Ethics and Regulation
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Ubiquitin and proteasome pathways

The Royal Melbourne Hospital
2012-2023

Peter MacCallum Cancer Centre
2021

Medizinische Hochschule Hannover
2020

The University of Melbourne
2002-2018

Melbourne Health
2012

Monash Medical Centre
2007

Biotechnology Institute
2006

Insecticide resistance is one of the most widespread genetic changes caused by human activity, but we still understand little about origins and spread resistant alleles in global populations insects. Here, via microarray analysis all P450s Drosophila melanogaster , show that DDT-R a gene conferring to DDT, associated with overtranscription single cytochrome P450 gene, Cyp6g1 . Transgenic shows this alone both necessary sufficient for resistance. Resistance up-regulation are allele has...

10.1126/science.1074170 article EN Science 2002-09-27

The increased transcription of the Cyp6g1 gene Drosophila melanogaster, and consequent resistance to insecticides such as DDT, is a widely cited example adaptation mediated by cis-regulatory change. A fragment an Accord transposable element inserted upstream causally associated with has spread high frequencies in populations around world since 1940s. Here we report existence natural allelic series at this locus D. involving copy number variation Cyp6g1, two additional insertions (a P...

10.1371/journal.pgen.1000998 article EN cc-by PLoS Genetics 2010-06-24

Transposable elements are a major mutation source and powerful agents of adaptive change. Some transposable element insertions in genomes increase to high frequency because the selective advantage mutant phenotype provides. Cyp6g1-mediated insecticide resistance Drosophila melanogaster is due upregulation cytochrome P450 gene Cyp6g1, leading variety classes. The Cyp6g1 correlated with presence long terminal repeat (LTR) an Accord retrotransposon inserted 291bp upstream transcription start...

10.1534/genetics.106.066597 article EN Genetics 2006-12-19
Jihoon E. Joo James G. Dowty Roger L. Milne Ee Ming Wong Pierre‐Antoine Dugué and 95 more Dallas R. English John L. Hopper David E. Goldgar Graham G. Giles Melissa C. Southey Adrienne Sexton Alice Christian Alison H. Trainer Allan D. Spigelman Andrew Fellows Andrew N. Shelling Anna de Fazio Anneke C. Blackburn Ashley Crook Bettina Meiser Briony Patterson Christine L. Clarke Christobel Saunders Clare Hunt Clare L. Scott David J. Amor Deborah J. Marsh Edward Edkins Elizabeth Salisbury Eric Haan Eveline Neidermayr Finlay Macrae Gelareh Farshid Geoffrey J. Lindeman Georgia Chenevix‐Trench Graham J. Mann Grantley Gill Heather Thorne Ian Campbell Ian B. Hickie Ingrid Winship Jack Goldblatt James M. Flanagan James Kollias Jane E. Visvader Jennifer Stone Jessica Taylor Jo Burke Jodi M. Saunus John Forbes Jonathan Beesley Judy Kirk Juliet D. French Kathy Tucker Kathy H. C. Wu Kelly‐Anne Phillips Lara Lipton Leslie Andrews Elizabeth Lobb Logan C. Walker Maira Kentwell Amanda B. Spurdle Margaret C. Cummings Margaret Gleeson Marion Harris Mark A. Jenkins Mary Anne Young Martin B. Delatycki Mathew Wallis Matthew Burgess Melanie A. Price Melissa A. Brown Michael Bogwitz Michael Field Michael Friedlander Michael Gattas Mona Saleh Nicholas K. Hayward Nick Pachter Paul A. Cohen Pascal H. G. Duijf Paul A. James Peter T. Simpson Peter C.C. Fong Phyllis Butow Rachael Williams Richard Kefford Rodney J. Scott Rosemary L. Balleine Sarah‐Jane Dawson Sheau Wen Lok Shona O’Connell Sian Greening Sophie Nightingale Stacey L. Edwards Stephen B. Fox Sue‐Anne McLachlan Sunil R. Lakhani Susan N. Thomas Yoland Antill

Abstract Mendelian-like inheritance of germline DNA methylation in cancer susceptibility genes has been previously reported. We aimed to scan the genome for heritable marks associated with breast by studying 25 Australian multiple-case families. Here we report genome-wide measured 210 peripheral blood samples provided family members using Infinium HumanMethylation450. develop and apply a new statistical method identify based on complex segregation analysis. estimate carrier probabilities...

10.1038/s41467-018-03058-6 article EN cc-by Nature Communications 2018-02-22

Lufenuron is an insect growth regulator insecticide mainly used for the control of cat flea. To understand mechanisms resistance to lufenuron, we have characterized lufenuron in a natural population Drosophila melanogaster . In this study precise genetic mapping identify mechanism resistance: overexpression cytochrome P450 gene Cyp12a4. Cyp12a4 predicted encode mitochondrial enzyme. Expression D. third-instar larvae was detected midgut and Malpighian tubules both lufenuron-resistant...

10.1073/pnas.0503709102 article EN Proceedings of the National Academy of Sciences 2005-08-24
Cristina Fortuño Bing Feng Courtney Carroll Giovanni Innella Wendy Kohlmann and 95 more Conxi Lázaro Joan Brunet Lídia Feliubadaló Sílvia Iglesias Mireia Menéndez Àlex Teulé Mandy L. Ballinger David M. Thomas Ainsley Campbell Mike Field Marion Harris Judy Kirk Nicholas Pachter Nicola Poplawski Rachel Susman Kathy Tucker Mathew Wallis Rachel Williams Elisa J. Cops David E. Goldgar Paul A. James Amanda B. Spurdle David J. Amor Lesley Andrews Yoland Antill Rosemary L. Balleine Jonathan Beesley Ian Bennett Michael Bogwitz Simon Bodek Leon Botes Meagan Brennan Melissa A. Brown Michael F. Buckley Jo Burke Phyllis Butow Liz Caldon Ian Campbell Michelle Cao Anannya Chakrabarti Deepa Chauhan Manisha Chauhan Georgia Chenevix‐Trench Alice Christian Paul A. Cohen Alison Colley Ashley Crook James Cui Eliza Courtney Margaret C. Cummings Sarah‐Jane Dawson Anna deFazio Martin Delatycki Rebecca Dickson Joanne Dixon Ted Edkins Stacey L. Edwards Gelareh Farshid Andrew Fellows Georgina Fenton Michael Field James M. Flanagan Peter C.C. Fong Laura Forrest Stephen B. Fox Juliet D. French Michael Friedlander Clara Gaff Mike Gattas Peter George Sian Greening Marion Harris Stewart Hart Nicholas K. Hayward John L. Hopper Cass Hoskins Clare Hunt Paul A. James Mark A. Jenkins Alexa Kidd Judy Kirk Jessica Koehler James Kollias Sunil R. Lakhani Mitchell Lawrence Jason S. Lee Shuai Li Geoffrey J. Lindeman Jocelyn Lippey Lara Lipton Liz Lobb Sherene Loi Graham J. Mann Deborah J. Marsh Sue Anne McLachlan

PURPOSE Establishing accurate age-related penetrance figures for the broad range of cancer types that occur in individuals harboring a pathogenic germline variant TP53 gene is essential to determine most effective clinical management strategies. These also permit optimal use cosegregation data classification variants unknown significance. Penetrance estimation can easily be affected by bias from ascertainment criteria, an issue not commonly addressed previous studies. MATERIALS AND METHODS...

10.1200/po.23.00453 article EN JCO Precision Oncology 2024-02-01
Anqi Li Felipe C. Geyer Pedro Blecua Ju Youn Lee Pier Selenica and 95 more David Brown Fresia Pareja Simon S. K. Lee Rahul Kumar Bárbara Rivera Rui Bi Salvatore Piscuoglio Hannah Y. Wen John R. Lozada Rodrigo Gularte‐Mérida Luca Cavallone Zoulikha Rezoug Tú Nguyen‐Dumont Paolo Peterlongo Carlo Tondini Thorkild Terkelsen Karina Rønlund Susanne E. Boonen Arto Mannerma Robert Winqvist Markéta Janatová Pathmanathan Rajadurai Bing Xia Larry Norton Mark E. Robson Pei-Sze Ng Lai‐Meng Looi Melissa C. Southey Britta Weigelt Teo Soo-Hwang Marc Tischkowitz William D. Foulkes Jorge S. Reis‐Filho Morteza Aghmesheh David J. Amor Leslie Andrews Yoland Antill Rosemary L. Balleine Jonathan Beesley Anneke C. Blackburn Michael Bogwitz Matthew A. Brown Matthew Burgess Jo Burke Phyllis Butow Liz Caldon Ian Campbell Alice Christian Christine L. Clarke Paul A. Cohen Ashley Crook James Cui Margaret C. Cummings Sarah‐Jane Dawson Anna de Fazio Martin B. Delatycki Alexander Dobrovic Tracy Dudding Pascal H. G. Duijf Edward Edkins Stacey L. Edwards Gelareh Farshid Andrew Fellows Michael Field James M. Flanagan Peter C.C. Fong John Forbes Laura Forrest Stephen B. Fox Juliet D. French Michael Friedlander David Gallego‐Ortega Michael Gattas Graham G. Giles Grantley Gill Margaret Gleeson Sian Greening Eric Haan Marion Harris Nicholas K. Hayward Ian B. Hickie John L. Hopper Clare Hunt Paul A. James Mark A. Jenkins Richard Kefford Maira Kentwell Judy Kirk James Kollias Sunil R. Lakhani Geoffrey J. Lindeman Lara Lipton Lizz Lobb Sheau Wen Lok Finlay Macrea

Mono-allelic germline pathogenic variants in the Partner And Localizer of BRCA2 (PALB2) gene predispose to a high-risk breast cancer development, consistent with role PALB2 homologous recombination (HR) DNA repair. Here, we sought define repertoire somatic genetic alterations PALB2-associated cancers (BCs), and whether BCs display bi-allelic inactivation and/or genomic features HR-deficiency (HRD). Twenty-four patients mutations were analyzed by whole-exome sequencing (WES, n = 16) or...

10.1038/s41523-019-0115-9 article EN cc-by npj Breast Cancer 2019-08-08
Anna Morra Nasim Mavaddat Taru Muranen Thomas U. Ahearn Jamie Allen and 95 more Irene L. Andrulis Päivi Auvinen Heiko Becher Sabine Behrens Carl Blomqvist Stig E. Bojesen Manjeet K. Bolla Hiltrud Brauch Nicola J. Camp Sara Carvalho Jose E. Castelao Melissa H. Cessna Jenny Chang‐Claude Georgia Chenevix‐Trench Kamila Czene Brennan Decker Joe Dennis Thilo Dörk Leila Dorling Alison M. Dunning Arif B. Ekici Mikael Eriksson D. Gareth Evans Peter A. Fasching Jonine D. Figueroa Henrik Flyger Manuela Gago‐Dominguez Montserrat García‐Closas Willemina R.R. Geurts-Giele Graham G. Giles Pascal Guénel Melanie Gündert Eric Hahnen Per Hall Ute Hamann Patricia Harrington Wei He Päivi Heikkilä Maartje J. Hooning Reiner Hoppe Sacha J. Howell Keith Humphreys Anna Jakubowska Audrey Jung Renske Keeman Vessela N. Kristensen Jan Lubiński Graham J. Mann Mehdi Manoochehri Siranoush Manoukian Sara Margolin Dimitrios Mavroudis Roger L. Milne Anna Marie Mulligan William G. Newman Tjoung‐Won Park‐Simon Paolo Peterlongo Paul D.P. Pharoah Valerie Rhenius Emmanouil Saloustros Elinor J. Sawyer Rita K. Schmutzler Mitul Shah Amanda B. Spurdle Ian Tomlinson Thérèse Truong Elke M. van Veen Maaike P.G. Vreeswijk Qin Wang Camilla Wendt Xiaohong R. Yang Heli Nevanlinna Peter Devilee Douglas F. Easton Marjanka K. Schmidt Kristine Kleivi Sahlberg Anne‐Lise Børresen‐Dale Inger Torhild Gram Karina Standahl Olsen Olav Engebråten Bjørn Naume Jürgen Geisler OSBREAC Grethe I.G. Alnæs David J. Amor Lesley Andrews Yoland Antill Rosemary L. Balleine Jonathan Beesley Ian Bennett Michael Bogwitz Leon Botes Meagan Brennan Melissa A. Brown Michael F. Buckley

Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral (CBC) risk cancer-specific survival (BCSS) is scarce. The aim of this study was to assess the association protein-truncating (PTVs) rare missense (MSVs) nine known (ATM, BARD1, CHEK2, PALB2, RAD51C, RAD51D, TP53) 25 suspected BC-susceptibility CBC BCSS. Hazard ratios (HRs) 95% confidence intervals (CIs) were estimated Cox regression models. Analyses...

10.1016/j.ajhg.2023.02.003 article EN cc-by-nc-nd The American Journal of Human Genetics 2023-02-23
Kelly‐Anne Phillips Joanne Kotsopoulos Susan M. Domchek Mary Beth Terry James A. Chamberlain and 95 more Julie K. Bassett Amber M. Aeilts Irene L. Andrulis Saundra S. Buys Wanda Cui Mary B. Daly Andrea Eisen William D. Foulkes Michael Friedlander Jacek Gronwald John L. Hopper Esther M. John Beth Y. Karlan Raymond H. Kim Allison W. Kurian Jan Lubiński Kelly Metcalfe Katherine L. Nathanson Christian F. Singer Melissa C. Southey Heather Symecko Nadine Tung Steven A. Narod Roger L. Milne David J. Amor Lesley Andrews Yoland Antill Rosemary L. Balleine Jonathan Beesley Ian Bennett Michael Bogwitz Simon Bodek Leon Botes Meagan Brennan Melissa A. Brown Michael F. Buckley Jo Burke Phyllis Butow Liz Caldon Ian Campbell Michelle Cao Anannya Chakrabarti Deepa Chauhan Manisha Chauhan Georgia Chenevix‐Trench Alice Christian Paul A. Cohen Alison Colley Ashley Crook James Cui Eliza Courtney Margaret C. Cummings Sarah‐Jane Dawson Anna deFazio Martin Delatycki Rebecca Dickson Joanne Dixon Stacey L. Edwards Gelareh Farshid Andrew Fellows Georgina Fenton Michael Field James M. Flanagan Peter C.C. Fong Laura Forrest Stephen Fox Juliet D. French Michael Friedlander Clara Gaff Mike Gattas Peter George Sian Greening Marion Harris Stewart Hart Philip Harraka Nicholas K. Hayward John L. Hopper Cass Hoskins Clare Hunt Paul A. James Mark A. Jenkins Alexa Kidd Judy Kirk Jessica Koehler James Kollias Sunil R. Lakhani Mitchell Lawrence Jason S. Lee Shuai Li Geoffrey J. Lindeman Jocelyn Lippey Lara Lipton Liz Lobb Sherene Loi Graham J. Mann

PURPOSE It is uncertain whether, and to what extent, hormonal contraceptives increase breast cancer (BC) risk for germline BRCA1 or BRCA2 mutation carriers. METHODS Using pooled observational data from four prospective cohort studies, associations between contraceptive use BC unaffected female carriers were assessed using Cox regression. RESULTS Of 3,882 1,509 carriers, 53% 71%, respectively, had ever used at least 1 year (median cumulative duration of use, 4.8 5.7 years, respectively)....

10.1200/jco.24.00176 article EN Journal of Clinical Oncology 2024-10-02

Abstract A model for practising genetic counselors to obtain clinical supervision via reciprocal peer observation and feedback was developed trialled. The in response a perceived lack of opportunity immediate observational counselors. aims reached by consensus were facilitate learning new approaches skills, revitalise current ways practising, enhance skills two‐way process, where the observer learnt from counselor, vice‐versa. agreed on process paired whereby present room during counseling...

10.1007/s10897-012-9540-8 article EN Journal of Genetic Counseling 2012-09-24

10.5694/mja13.11218 article EN The Medical Journal of Australia 2013-11-01
Mark J. McCabe Marie Gauthier Chia-Ling Chan Tanya Thompson Sunita M. C. De Sousa and 95 more Clare Puttick John P. Grady Velimir Gayevskiy Tao Jiang Kevin Ying Arcadi Cipponi Niantao Deng Alexander Swarbrick Mélissa Thomas Reginald V. Lord Amber L. Johns Maija Kohonen‐Corish Sandra O’Toole Jonathan R. Clark Simon A. Mueller Ruta Gupta Ann McCormack Marcel E. Dinger Mark J. Cowley Morteza Aghmesheh David J. Amor Lesley Andrews Yoland Antill Shane Armitage Leanne Arnold Rosemary L. Balleine Patti Bastick Jonathan Beesley John Beilby Ian Bennett Anneke C. Blackburn Michael Bogwitz Leon Botes Meagan Brennan Melissa A. Brown Michael F. Buckley Matthew Burgess Jo Burke Phyllis Butow Liz Caldon David F. Callen Ian Campbell Deepa Chauhan Manisha Chauhan Georgia Chenevix‐Trench Alice Christian Christine L. Clarke Paul A. Cohen Alison Colley Ashley Crook James Cui Bronwyn Culling Margaret C. Cummings Sarah‐Jane Dawson Anna deFazio Martin Delatycki Rebecca Dickson Joanne Dixon Alexander Dobrovic Tracy Dudding Ted Edkins Stacey L. Edwards Maurice Eisenbruch Gelareh Farshid Andrew Fellows Georgina Fenton Michael Field James M. Flanagan Peter C.C. Fong Laura Forrest Stephen B. Fox Juliet D. French Michael Friedlander Clara Gaff Davi Gallego Ortega Mike Gattas Peter George Graham G. Giles Grantley Gill Sian Greening Eric Haan Marion Harris Stewart Hart Nicholas K. Hayward Louise Heiniger John L. Hopper Clare Hunt Paul A. James Mark A. Jenkins Richard Kefford Alexa Kidd Judy Kirk Jessica Koehler James Kollias Sunil R. Lakhani

Abstract Next generation sequencing has revolutionised genomic studies of cancer, having facilitated the development precision oncology treatments based on a tumour’s molecular profile. We aimed to develop targeted gene panel for application disparate cancer types with particular focus tumours head and neck, plus test utility in liquid biopsy. The final designed through Roche/Nimblegen combined 451 cancer-associated genes (2.01 Mb target region). 136 patient DNA samples were collected...

10.1038/s41598-019-52000-3 article EN cc-by Scientific Reports 2019-11-19

Background Gorlin syndrome (nevoid basal cell carcinoma syndrome) is a rare genetic predisposition to carcinomas ( BCC ), keratocysts of the jaw and calcification falx cerebri among other clinical features. With advent sonic hedgehog inhibitors for treatment , it timely establish cohort individuals with collect standardised phenotypic information on these individuals. Moreover, health‐related quality life QoL ) in not well studied. Aim To Victorian study Methods Phenotypic data were obtained...

10.1111/imj.13429 article EN Internal Medicine Journal 2017-03-23

To describe patient characteristics, standard operating procedure, and uptake of genetic testing at the multidisciplinary Cardiac Genetics Clinic (CGC) Royal Melbourne Hospital during its first 6 years.Database exploration referral diagnoses, sex, number clinic visits incidence in a population individuals attending CGC.Tertiary hospital (Royal Hospital) providing cardiac genetics services to state Victoria.All initially between July 2007 2013, either as proband or an at-risk family...

10.5694/mja14.01674 article EN The Medical Journal of Australia 2015-09-01

The present study aims to describe the phenotypic features of patients with hereditary haemorrhagic telangiectasia (HHT) seen at Royal Melbourne Hospital, Victoria, Australia, and customise a protocol for surveillance HHT.This is retrospective in tertiary referral hospital all referred Clinical Genetics Service between 2007 2011 suspected diagnosis HHT. Data abstracted from patient clinical records were analysed features, types HHT genetic testing results where available.Our cohort...

10.1111/imj.12457 article EN Internal Medicine Journal 2014-04-22

Abstract Internationally, the practice of offering additional findings (AFs) when undertaking a clinically indicated genomic test differs. In USA, recommendation is to include analysis for AFs alongside diagnostic analysis, unless patient opts‐out, whereas European and Canadian guidelines recommend opt‐in models. These all consider offer as an activity concurrent with testing. This paper describes novel two‐step model managing within healthcare system in Victoria, Australia presents study...

10.1002/jgc4.1102 article EN Journal of Genetic Counseling 2019-02-18
Rachel Austin Jaye S. Brown Sarah Casauria Evanthia O. Madelli Tessa Mattiske and 95 more Tiffany Boughtwood Alejandro Metke Andrew M. Davis Ari Horton David S. Winlaw Debjani Das Magdalena Soka Eleni Giannoulatou Emma M. Rath Eric Haan Gillian M. Blue Jitendra K. Vohra J. Atherton Karin van Spaendonck‐Zwarts Kathy Cox Leslie Burnett Mathew Wallis Matilda Haas Michael C. Quinn Nicholas Pachter Nicola Poplawski Zornitza Stark Richard D. Bagnall Robert G. Weintraub Sarah‐Jane Pantaleo Sebastian Lunke Paul De Fazio T. Thompson Paul A. James Yu‐Chen Chang Diane Fatkin Ivan Macciocca Jodie Ingles Sally L. Dunwoodie Chris Semsarian Julie McGaughran Lesley C. Adès A. Juanico Enríquez Alison McLean Renee Smyth Dimithu Alankarage Diane Fatkin James W. McNamara Magdalena Soka Morgan almog Vanessa S. Fear C. Medi Zornitza Stark Mohammad Al-Shinnag Miriam Fine Alejandro Metke Raymond W. Sy J. Atherton Keri Finlay Di Milnes Dotti Tang Rachel Austin Denisse Garza Michael R. Milward Jessica Taylor Richard D. Bagnall Eleni Giannoulatou A. Morrish Shelby Taylor Chris Barnett Laura Gongolidis Jim Morwood Michel Tchan Gillian M. Blue Belinda Gray Helen Mountain T. Thompson Simon Bodek C. A. Greer David Mowat Jordan Thorpe Kirsten Boggs Eric Haan Chai‐Ann Ng Alison H. Trainer Michael Bogwitz Mathilda Haas N. Nowak Gunjan Trivedi Tiffany Boughtwood Bernadette Hanna Noelia Nunez Martinez Giulia Valente Alessandra Bray Richard P. Harvey Monique Ohanian Karin van Spaendonck‐Zwarts Marie‐Jo Brion Janette Hayward S. S. O'Sullivan

The Australian Genomics Cardiovascular Disorders Flagship was a national multidisciplinary collaboration. It aimed to investigate the feasibility of genome sequencing (GS) and functional genomics resolve variants uncertain significance (VUS) in clinical management patients families with cardiomyopathies, primary arrhythmias, congenital heart disease (CHD).

10.1016/j.gimo.2024.101842 article EN cc-by-nc-nd Genetics in Medicine Open 2024-01-01
Jasmine A. McDonald Yuyan Liao Julia A. Knight Esther M. John Allison W. Kurian and 95 more Mary Daly Saundra S. Buys Yun Huang Caren J. Frost Irene L. Andrulis Sarah V. Colonna Michael Friedlander John L. Hopper Wendy K. Chung Jeanine M. Genkinger Robert J. MacInnis Mary Beth Terry David J. Amor Lesley Andrews Yoland Antill Rosemary Balleine Jonathan Beesley Ian Bennett Michael Bogwitz Simon Bodek Leon Botes Meagan Brennan Matthew A. Brown Michael F. Buckley Jo Burke Phyllis Butow Liz Caldon Ian Campbell Michelle Cao Anannya Chakrabarti Deepa Chauhan Manisha Chauhan Georgia Chenevix‐Trench Alice Christian Paul R. Cohen Alison Colley Ashley Crook James Cui Eliza Courtney Margaret C. Cummings Sarah‐Jane Dawson Anna deFazio Martin Delatycki Rebecca Dickson Joanne Dixon Stacey L. Edwards Gelareh Farshid Andrew Fellows Georgina Fenton Michael Field James M. Flanagan Peter C.C. Fong Laura Forrest Stephen Fox Juliet D. French Michael Friedlander Clara Gaff Mike Gattas Peter George Sian Greening Marion Harris Stewart Hart Philip Harraka Nicholas K. Hayward John L. Hopper Cass Hoskins Clare Hunt Paul A. James Mark A. Jenkins Alexa Kidd Judy Kirk Jessica Koehler James Kollias Sunil R. Lakhani Mitchell Lawrence Jason S. Lee Shuai Li Geoffrey J. Lindeman Jocelyn Lippey Lara Lipton Liz Lobb Sherene Loi Graham J. Mann Deborah J. Marsh Sue Anne McLachlan Bettina Meiser Roger L. Milne Sophie Nightingale Shona O’Connell Sarah O’Sullivan David Gallego‐Ortega Nick Pachter Jia‐Min Pang Gargi Pathak Briony Patterson

Importance Few studies have investigated whether the associations between pregnancy-related factors and breast cancer (BC) risk differ by underlying BC susceptibility. Evidence regarding variation in is critical to understanding causes for developing effective risk-based screening guidelines. Objective To examine association risk, including modification a of where scores are based on age family history. Design, Setting, Participants This cohort study included participants from prospective...

10.1001/jamanetworkopen.2024.27441 article EN cc-by-nc-nd JAMA Network Open 2024-08-26

Objective: Hereditary Haemorrhagic Telangiectasia (HHT) is a genetic condition causing frequent nose bleeds, skin lesions (telangiectasia) and arteriovenous malformations. Approximately, 50% of people experience life-threatening HHT symptoms including haemorrhages in the brain, lungs liver. This study aimed to gain qualitative understanding psychosocial impact over time. Design: Using phenomenological framework, rigorous narrative analysis was performed on 20 semi-structured interviews with...

10.1080/08870446.2019.1583341 article EN Psychology and Health 2019-03-31
Coming Soon ...